T32AI153020 (ALEGRE, MARIA-LUISA ;SWARTZ, MELODY ANN)Aug 19, 2021 - Jul 31, 2026 NIH Immunoengineering Postdoctoral Training Program - Resubmission - 1 Role: Principal Investigator |
|
R01CA253248 (SWARTZ, MELODY ANN)Aug 1, 2021 - Jul 31, 2026 NIH Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface Role: Principal Investigator |
|
R01CA219304 (SWARTZ, MELODY ANN)Apr 1, 2018 - Mar 31, 2023 NIH Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01 Role: Principal Investigator |
|
R21AI130821 (SWARTZ, MELODY ANN)Feb 1, 2017 - Jan 31, 2019 NIH Immunomodulatory roles of lymphatic vessels in allergic airway inflammation Role: Principal Investigator |
|
R13HL123218 (SWARTZ, MELODY ANN)Mar 7, 2014 - Mar 6, 2015 NIH 2014 Molecular Mechanisms in Lymphatic Function and Disease Gordon Research Confe Role: Principal Investigator |
|
R01HL096539 (RANDOLPH, GWENDALYN J)Aug 5, 2009 - Dec 31, 2013 NIH Cholesterol and Lymphatic Transport of Molecules and Cells Role: Co-Principal Investigator |
|
R01HL075217 (SWARTZ, MELODY A)Sep 30, 2003 - May 31, 2008 NIH Lymph vs. blood angiogenesis: functional differences in* Role: Principal Investigator |